This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Antibody Engineering & Therapeutics US
December 13 - 16, 2023
Marriott Marquis San DiegoLive In-Person Event: December 13 - 16, 2023

Norio Hamamatsu, PhD
Senior Director at RevolKa Ltd.

Profile

Norio Hamamatsu is Senior Director and Head of US office at RevolKa Ltd. Before joining RevolKa, Norio was a principal scientist at Novartis Institutes for Biomedical Research, Inc., and led multiple biologics projects of both antibody and protein therapeutics. He graduated from Kyoto University and received his Ph.D. from Saitama University, where his research focused on protein engineering and directed evolution of proteins. He reported unique methods to explore protein fitness landscapes.

Agenda Sessions

  • Therapeutic Antibody Engineering for Highly Stable Formulations by Using a Machine Learning-guided Protein Engineering Technique, aiProtein®

    1:45pm